Gestational Diabetes Mellitus
Quick facts | emergency priorities
Clinical summary: This entry requires a disease-specific recognition, red-flag and emergency-management review. Refer to the underlying article and current local pathway; do not use this panel as a treatment protocol.
Browse the Endocrinology textbook: Endocrinology: Emergencies (specialty landing page only; no disease-level match confirmed)
References: Existing source link (not yet checked)
Editorial draft: the full historic text, doses, and pathways have not been clinically signed off. Cross-check BNF/BNFC and local protocols.
🩺 UK clinical review — 4 November 2026
Gestational diabetes — pregnancy-specific glucose targets
- Use NICE NG3 pregnancy-specific assessment and targets rather than adult type 2 diabetes thresholds. Discuss individualised capillary glucose goals and hypoglycaemia risk with the antenatal diabetes team.
- NICE provides targets of fasting glucose below 5.3 mmol/L, one-hour post-meal below 7.8 mmol/L or two-hour post-meal below 6.4 mmol/L when achievable without problematic hypoglycaemia.
- Medicine choice and antenatal fetal surveillance depend on gestational age, prior glycaemic control and the pregnancy pathway; avoid automatic transfer of a non-pregnant prescribing regimen.
Guideline: current UK source. Targeted update only; the retained historical article requires full professional review, especially doses and pathways.
Related Subjects:
|Diabetes Mellitus: Basics
|Type 1 Diabetes Mellitus
| Type 2 Diabetes Mellitus
| Type 3c Diabetes Mellitus
|Insulin Physiology
|Gestational Diabetes
|HbA1c
|Hyperglycaemic Hyperosmolar State (HHS)
|Diabetic Nephropathy
|Diabetic Retinopathy
|Diabetic Neuropathy
|Diabetic Amyotrophy
|Maturity Onset Diabetes of the Young (MODY)
|Diabetes: Complications
|Hypoglycaemia
|Diabetic Ketoacidosis (DKA) Adults
|Alcoholic Ketoacidosis
|Euglycaemic Ketoacidosis (euDKA) with SGLT2 Inhibitors
|Causes of Ketoacidosis
|Gold Score: Hypoglycaemia Awareness in Type 1 Diabetes
🤰 Diabetes in Pregnancy includes pre-existing type 1 or type 2 diabetes and gestational diabetes mellitus (GDM).
Blood glucose may fall early in pregnancy, but insulin resistance usually rises in the 2nd and 3rd trimester because of placental hormones 🌸.
Good glycaemic control reduces maternal, fetal and neonatal complications 🩸.
📖 About
- Gestational diabetes is diabetes first diagnosed during pregnancy.
- Glycosuria is common in pregnancy because the renal glucose threshold is lower, so urine glucose alone is not diagnostic.
- Placental hormones, including human placental lactogen, progesterone and cortisol, increase insulin resistance in later pregnancy.
- Insulin requirements often rise in the 2nd and 3rd trimester.
- After delivery, insulin resistance falls rapidly once the placenta is delivered.
🧬 Pathophysiology
- Pregnancy is a state of progressive insulin resistance.
- In susceptible women, pancreatic ß-cells cannot produce enough extra insulin to overcome this resistance.
- This leads to maternal hyperglycaemia.
- Glucose crosses the placenta, but maternal insulin does not.
- The fetus responds by producing more insulin, which promotes growth and increases the risk of macrosomia and neonatal hypoglycaemia.
⚠️ Risk Factors for Gestational Diabetes
- BMI above 30 kg/m².
- Previous macrosomic baby weighing 4.5 kg or more.
- Previous gestational diabetes.
- First-degree relative with diabetes.
- Family origin with higher diabetes prevalence, including South Asian, Black Caribbean and Middle Eastern backgrounds.
🔎 NICE Diagnostic Criteria for Gestational Diabetes
NICE recommends diagnosing gestational diabetes using a 75 g 2-hour oral glucose tolerance test if either threshold is met.
| Test |
Diagnostic threshold for GDM |
| Fasting plasma glucose |
≥ 5.6 mmol/L |
| 2-hour plasma glucose after 75 g OGTT |
≥ 7.8 mmol/L |
🧪 Screening
- Screen women with risk factors using a 75 g 2-hour OGTT.
- For most high-risk women, offer OGTT at 24–28 weeks.
- If there was previous gestational diabetes, offer early self-monitoring of blood glucose or an early OGTT, then repeat testing at 24–28 weeks if early testing is normal.
- Do not rely on glycosuria alone to diagnose gestational diabetes.
- HbA1c may help identify pre-existing diabetes, but OGTT is used for NICE diagnosis of GDM.
🎯 Blood Glucose Targets in Pregnancy
Targets should be individualised and achieved without causing troublesome hypoglycaemia.
| Timing |
Target |
| Fasting glucose |
< 5.3 mmol/L |
| 1 hour after meals |
< 7.8 mmol/L |
| 2 hours after meals |
< 6.4 mmol/L |
| During labour and birth |
Usually 4.0–7.0 mmol/L |
🛠️ Management
- Provide care through a multidisciplinary diabetes-in-pregnancy team.
- Give specialist dietary advice, including carbohydrate awareness and healthy eating.
- Encourage safe physical activity if appropriate.
- Teach regular capillary blood glucose monitoring.
- If glucose targets are not met with diet and exercise, consider metformin.
- If metformin is contraindicated, not tolerated or insufficient, offer insulin.
- Insulin may be needed immediately if glucose is very high at diagnosis or if there are complications such as suspected macrosomia or hydramnios.
💊 Medication
- Insulin: Safe and effective in pregnancy; used when targets are not met or hyperglycaemia is significant.
- Metformin: May be used in pregnancy when benefits outweigh potential harms.
- Other oral glucose-lowering drugs: Usually stopped in pre-existing diabetes and replaced with insulin, except metformin when appropriate.
- Pre-existing diabetes: Requires specialist review of medication, retinal status, renal function and pregnancy risks.
👁️ Monitoring for Pre-existing Diabetes
- Assess renal function and urinary albumin:creatinine ratio.
- Offer retinal assessment because diabetic retinopathy can worsen during pregnancy.
- Monitor blood pressure and urine protein because pre-eclampsia risk is increased.
- Use ultrasound surveillance to monitor fetal growth and amniotic fluid volume.
👶 Fetal and Obstetric Monitoring
- Offer serial ultrasound assessment of fetal growth and amniotic fluid volume.
- Assess for macrosomia and polyhydramnios.
- Discuss timing and mode of birth with the obstetric and diabetes team.
- Consider shoulder dystocia risk if fetal macrosomia is suspected.
⚠️ Risks of Diabetes in Pregnancy
- Maternal: Pre-eclampsia, operative delivery, worsening retinopathy in pre-existing diabetes, and future type 2 diabetes after GDM.
- Fetal: Macrosomia, polyhydramnios, shoulder dystocia, birth trauma and stillbirth risk if control is poor.
- Neonatal: Hypoglycaemia, respiratory distress, jaundice and admission to neonatal care.
- Pre-existing diabetes: Poor early glycaemic control increases risk of congenital malformations and miscarriage.
🏥 Labour and Birth
- Monitor capillary blood glucose regularly during labour.
- Aim to keep glucose usually between 4.0 and 7.0 mmol/L during labour and birth.
- Use local protocol for variable-rate IV insulin infusion if glucose is outside target or if clinically indicated.
- Neonatal team should be aware because babies are at risk of hypoglycaemia after birth.
🍼 After Birth
- Insulin requirements fall rapidly after delivery.
- Women with gestational diabetes can usually stop glucose-lowering treatment immediately after birth unless hyperglycaemia persists.
- Encourage breastfeeding where possible.
- Check for persistent diabetes after pregnancy.
- Give lifestyle advice because future type 2 diabetes risk is increased.
🔁 Postnatal Follow-Up After GDM
- Offer fasting plasma glucose testing 6–13 weeks after birth, or HbA1c after 13 weeks if fasting glucose was not done.
- Advise annual HbA1c testing thereafter to screen for type 2 diabetes.
- Advise weight management, healthy diet and physical activity.
- In future pregnancies, arrange early testing because recurrence risk is increased.
💡 Clinical Pearl:
Screen women with NICE risk factors, such as BMI above 30 kg/m², previous gestational diabetes, previous baby ≥4.5 kg, first-degree family history of diabetes, or higher-risk ethnic background.
In the UK, most high-risk women are offered a 75 g OGTT at 24–28 weeks.
📚 Case Example
👩 A 32-year-old woman with BMI 34 kg/m² attends at 26 weeks.
A 75 g OGTT shows fasting glucose 6.2 mmol/L and 2-hour glucose 9.8 mmol/L.
✅ Diagnosis: Gestational diabetes, because fasting glucose is ≥5.6 mmol/L and 2-hour glucose is ≥7.8 mmol/L.
🛠️ Management: Specialist dietetic advice, blood glucose monitoring, exercise advice if safe, and metformin or insulin if targets are not met.
⚠️ Delivery planning should consider fetal growth, macrosomia risk and neonatal hypoglycaemia risk.
🧠 Exam Pearls
- NICE GDM diagnosis: fasting glucose ≥5.6 mmol/L or 2-hour OGTT ≥7.8 mmol/L.
- Pregnancy glucose targets: fasting <5.3, 1-hour <7.8, 2-hour <6.4 mmol/L.
- Glucose crosses the placenta; insulin does not.
- Fetal hyperinsulinaemia causes macrosomia and neonatal hypoglycaemia.
- After delivery, insulin resistance falls quickly because the placenta has been delivered.
📚 Summary
Diabetes in pregnancy requires early recognition, careful glucose monitoring and multidisciplinary care.
NICE diagnoses gestational diabetes using a 75 g OGTT with fasting glucose ≥5.6 mmol/L or 2-hour glucose ≥7.8 mmol/L.
Good control reduces risks such as pre-eclampsia, macrosomia, shoulder dystocia and neonatal hypoglycaemia.
Additional related clinical topics
Diabetes and Pregnancy
🧩 Diabetes in Pregnancy
- Pre-existing diabetes:
- Type 1 → insulin dependent, autoimmune, usually diagnosed in youth.
- Type 2 → insulin resistance ± relative deficiency, associated with obesity.
- Gestational diabetes (GDM):
- Diabetes diagnosed during pregnancy (not overt pre-existing).
- Typically detected in 2nd–3rd trimester via OGTT.
- Risk factors: age >25, BMI >30, previous GDM, macrosomic baby (>4.5kg), family history, non-Caucasian background, HIV positive.
⚠️ Risks in Pregnancy
- For the Mother:
- Hypertension, pre-eclampsia, miscarriage, preterm labour.
- Hypoglycaemia unawareness (esp. in T1DM).
- Progression of retinopathy and nephropathy.
- Higher caesarean section rates.
- Increased lifetime risk of T2DM (esp. after GDM).
- For the Baby:
- Macrosomia → shoulder dystocia, birth trauma.
- Congenital malformations (if poor control at conception).
- Neonatal hypoglycaemia (due to fetal hyperinsulinism).
- ↑ risk of obesity and T2DM in later life.
🛠️ Management Strategies
- Preconception:
- Optimise HbA1c (<48 mmol/mol if safe).
- Weight optimisation, lifestyle advice.
- Stop unsafe meds (ACEi, statins, some oral hypoglycaemics).
- Folic acid 5 mg/day until 12 weeks.
- During pregnancy:
- Frequent CBG monitoring (≥4x/day) or CGM/flash monitoring.
- Eye and renal screening early in pregnancy.
- OGTT at booking if risk factors.
- Insulin is mainstay (oral agents avoided except metformin if risk-benefit considered).
- Ultrasound & growth scans to monitor macrosomia/polyhydramnios.
- Targets (NICE):
- Fasting: 5.0–7.0 mmol/L.
- Pre-meal: 4.0–7.0 mmol/L.
- Test blood ketones if hyperglycaemic or unwell.
- If Type 1 Diabetes:
- Offer CGM (continuous glucose monitoring).
- Alternative: Flash glucose monitor (Libre).
- If non–Type 1 Diabetes:
- CGM may still be offered if poor control.
- Increase monitoring if meds adjusted.
🍼 Postpartum Care
- Mother:
- Insulin needs usually fall rapidly after delivery.
- Check fasting glucose at 6 weeks postpartum (esp. after GDM).
- Half of women with GDM develop T2DM long-term → lifelong screening needed.
- Baby:
- Monitor for neonatal hypoglycaemia and respiratory distress.
- Ongoing paediatric review for growth and metabolic risk.
- Breastfeeding:
- Encouraged – improves maternal glycaemia and reduces child’s diabetes risk.
- May require reduced insulin doses due to increased energy demands.
📚 Teaching Pearls
- Poor glycaemic control at conception → highest risk of congenital malformations.
- ACE inhibitors & statins are teratogenic – must be stopped preconception.
- Metformin sometimes continued in GDM or T2DM, but insulin is gold standard.
- Always think macrosomia → shoulder dystocia risk in OSCE stations.
- Women with GDM require lifelong annual diabetes screening.
🔗 References